The Emergence of COVID-19 to Augment the Enteric Disease Testing Market Growth

Enteric diseases are caused by micro-organisms such as parasites, bacteria, and viruses that cause intestinal illness. Enteric disease is caused by bacteria that are found inside of the small intestine. The term enteric describes the area where these bacteria attach to the lining of the small intestine, and it is generally thought that there are approximately five hundred different strains of this type of bacteria.

An individual is not necessarily at risk for developing enteric disease, but those who have a family history of the disease are particularly at risk. Enteric diseases most often result from consuming contaminated water or food and some can spread from person to person.

Market Dynamics:

The emergence of COVID-19 (the novel coronavirus) is expected to propel the growth of the enteric disease testing market. For instance, according to the World Health Organization (WHO), worldwide, as of 5:01pm CET, 11 February 2021, there have been 106,991,090 confirmed cases of COVID-19, including 2,347,015 deaths.

Increasing prevalence of enteric diseases worldwide and increasing launches and approvals of new products are expected to drive the enteric disease testing market growth. For instance, in October 2019, Mobidiag received CE-IVD marking for its Novodiag Stool Parasites test for the detection of intestinal parasites from stool samples.

Favorable government initiatives in both developed and developing countries to improve the awareness among people about the availability of enteric disease tests are expected to augment the growth of the enteric disease testing market. For instance, government of emerging economies actively participates in various campaigns to promote benefits of enteric tests.

Campylobacter outbreak is also expected to fuel the growth of the enteric disease testing market. For instance, in August 2020, Lindsay Farm recalled raw drinking milk after one person needed hospital treatment for a Campylobacter infection.

However, lack of awareness among people about enteric disease, particularly in emerging economies, is expected to restrain the enteric disease testing market growth.

Competitive Analysis:

Major players operating in the enteric disease testing market are Trinity Biotech, Quest Diagnostics, Meridian Bioscience, Inc., Alere, Inc., DiaSorin, Coris BioConcept, Cepheid, Bio-Rad, bioMerieux, Biomerica, Inc., and Becton Dickinson & Company.

Major players in the market are adopting various strategies, such as product launch, to expand their product portfolio. For instance, in 2019, ERADA launched saliva-based diagnostic tool, Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART), for detection of parasites causing malaria.